Phase Ib study of zotiraciclib in recurrent high-grade gliomas meets its prespecified endpoint Jan. 14, 2021
Initiation of pivotal global study evaluating CLR-131 in Waldenstrom's macroglobulinemia Jan. 13, 2021
Helsinn begins phase I/II study of oral RET inhibitor TAS-0953 in advanced solid tumors Jan. 12, 2021
Chipscreen Biosciences submits IND to the NMPA for pivotal phase III study of chiauranib in SCLC Jan. 12, 2021
RSS